Cargando…
COPD, but Not Asthma, Is Associated with Worse Outcomes in COVID-19: Real-Life Data from Four Main Centers in Northwest Italy
Introduction: Asthma, along with inhaled steroids, was initially considered a risk factor for worse clinical outcomes in COVID-19. This was related to the higher morbidity observed in asthma patients during previous viral outbreaks. This retrospective study aimed at evaluating the prevalence of asth...
Autores principales: | Nicola, Stefania, Borrelli, Richard, Ridolfi, Irene, Bernardi, Virginia, Borrelli, Paolo, Guida, Giuseppe, Antonelli, Andrea, Albera, Carlo, Marengo, Stefania, Briozzo, Antonio, Norbiato, Claudio, Frazzetto, Agata Valentina, Saad, Marina, Lo Sardo, Luca, Bacco, Beatrice, Gallo Cassarino, Silvia, Della Mura, Stefano, Bagnasco, Diego, Bucca, Caterina, Rolla, Giovanni, Solidoro, Paolo, Brussino, Luisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321539/ https://www.ncbi.nlm.nih.gov/pubmed/35887681 http://dx.doi.org/10.3390/jpm12071184 |
Ejemplares similares
-
Biologics in Severe Eosinophilic Asthma: Three-Year Follow-Up in a SANI Single Center
por: Solidoro, Paolo, et al.
Publicado: (2022) -
IL-17 Promotes Nitric Oxide Production in Non-Small-Cell Lung Cancer
por: Nicola, Stefania, et al.
Publicado: (2021) -
Is it severe asthma or asthma with severe comorbidities?
por: Brussino, Luisa, et al.
Publicado: (2017) -
Acquired Factor XI Deficiency during SARS-CoV-2 Infection: Not Only Thrombosis
por: Andreani, Giacomo, et al.
Publicado: (2020) -
Triple Therapy in COPD: Can We Welcome the Reduction in Cardiovascular Risk and Mortality?
por: Solidoro, Paolo, et al.
Publicado: (2022)